Hemab
Drug DiscoveryWebsite
Developer of prophylactic therapeutics designed for bleeding and thrombosis disorders. The company's therapeutics accumulate, modulate, balance, and at times recruit endogenous clotting factors alread...
Valuation
$0
Share Price
N/A
Total Raised
$353M
Last Round
Later Stage VC (Series C)
Oct 2025
Latest Funding Round
Later Stage VC (Series C)
Oct 27, 2025
$157M
raised
Investors
+12 other investors